RT Journal Article
SR Electronic
T1 Predicting age from 100,000 one week-long 100Hz wrist accelerometer records of physical activity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.21.21259265
DO 10.1101/2021.06.21.21259265
A1 Alan Le Goallec
A1 Sasha Collin
A1 M’Hamed Jabri
A1 Samuel Diai
A1 Théo Vincent
A1 Chirag J. Patel
YR 2021
UL http://medrxiv.org/content/early/2021/06/25/2021.06.21.21259265.abstract
AB Physical activity improves quality of life, physical health and mental health, and is also an important protective factor against highly prevalent age-related diseases such as cardiovascular diseases, diabetes, cancer and mental health. With age, physical activity tends to decrease, leading down a vicious cycle that increases vulnerability to disease in the elderly. In the following, we trained neural network architectures to predict age from 115,456 one week-long 100Hz wrist accelerometer recordings from the UK Biobank (R-Squared=63.5±2.4%; root mean squared error=4.7±0.1 years). We achieved this performance by preprocessing the raw data as 2,271 scalar features, 113 time series and four images. We also considered the raw signal at different time scales (weekly activity patterns vs. gait). We then defined accelerated aging for a participant as being predicted older than one’s actual age and aimed to characterize these participants. We performed a genome wide association on the accelerated aging phenotypes to estimate its heritability (h_g2=12.3±0.9%) and identified nine single nucleotide polymorphisms in seven genes associated with it (e.g HIST1H4L, involved in chromatin organization). Similarly, we identified biomarkers (e.g blood pressure), clinical phenotypes (e.g chest pain), diseases (e.g hypertension), environmental (e.g smoking) and socioeconomic (e.g income and education) variables associated with accelerated aging. We conclude that physical activity-derived biological age is a complex phenotype with both genetic and non-genetic factors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding: NIEHS R00 ES023504; NIEHS R21 ES25052; NIAID R01 AI127250; NSF 163870; MassCATS, Massachusetts Life Science Center; Sanofi. The funders had no role in the study design or drafting of the manuscript(s).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Harvard internal review board (IRB) deemed the research as non-human subjects research (IRB: IRB16-2145).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe used the UK Biobank (project ID: 52887). The code can be found at https://github.com/Deep-Learning-and-Aging. The results can be interactively and extensively explored at https://www.multidimensionality-of-aging.net/. We will make the biological age phenotypes available through UK Biobank upon publication. The GWAS results can be found at https://www.dropbox.com/s/59e9ojl3wu8qie9/Multidimensionality_of_aging-GWAS_results.zip?dl=0. https://github.com/Deep-Learning-and-Aging https://www.multidimensionality-of-aging.net/ https://www.dropbox.com/s/59e9ojl3wu8qie9/Multidimensionality_of_aging-GWAS_results.zip?dl=0